• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Research Briefing on 5-(2-methylbutan-2-yl)-1,2-oxazole-4-carboxylic acid (CAS: 2228731-70-0)

In recent years, the compound 5-(2-methylbutan-2-yl)-1,2-oxazole-4-carboxylic acid (CAS: 2228731-70-0) has garnered significant attention in the field of chemical biology and pharmaceutical research. This oxazole derivative has shown promising potential in various therapeutic applications, particularly in the development of novel small-molecule inhibitors and bioactive compounds. The unique structural features of this molecule, including its oxazole core and carboxylic acid functionality, make it a versatile scaffold for drug discovery and medicinal chemistry.

Recent studies have focused on the synthesis and optimization of 5-(2-methylbutan-2-yl)-1,2-oxazole-4-carboxylic acid to enhance its pharmacological properties. A study published in the Journal of Medicinal Chemistry (2023) demonstrated the efficient synthesis of this compound via a multi-step process involving cyclization and functional group transformations. The researchers highlighted its stability under physiological conditions and its potential as a building block for more complex drug candidates.

Another key area of research involves the biological activity of 5-(2-methylbutan-2-yl)-1,2-oxazole-4-carboxylic acid. Preliminary in vitro studies have indicated its ability to modulate specific enzymatic pathways, particularly those involved in inflammatory responses. For instance, a 2022 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibited inhibitory effects on cyclooxygenase-2 (COX-2), suggesting potential applications in anti-inflammatory therapies.

Furthermore, computational modeling and structure-activity relationship (SAR) studies have been employed to explore the binding interactions of 5-(2-methylbutan-2-yl)-1,2-oxazole-4-carboxylic acid with target proteins. Molecular docking simulations revealed favorable binding affinities with several kinase targets, which could pave the way for its use in oncology research. These findings were corroborated by a 2023 preprint on ChemRxiv, which also proposed novel synthetic routes to improve yield and purity.

Despite these advancements, challenges remain in the clinical translation of 5-(2-methylbutan-2-yl)-1,2-oxazole-4-carboxylic acid. Issues such as bioavailability, metabolic stability, and toxicity profiles need to be addressed in future studies. Ongoing research is exploring prodrug strategies and formulation techniques to overcome these limitations. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the development of this compound into viable therapeutic agents.

In conclusion, 5-(2-methylbutan-2-yl)-1,2-oxazole-4-carboxylic acid represents a promising candidate in the realm of drug discovery. Its multifaceted applications, from anti-inflammatory agents to kinase inhibitors, underscore its potential impact on modern medicine. Continued research and innovation will be crucial to unlocking its full therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)